Immunotherapy of Cancer

Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy.- Characterization of Regulatory T Cells in Tumor Suppressive Microenvironments.- Generation of Cytotoxic T Lymphocytes for Immunotherapy of EBV-Associated Malignancies.- Acquisition, Preparation, and Functional Assessment of Human NK Cells for Adoptive Immunotherapy.- Enhanced Migration of Human Dendritic Cells Expressing Inducible CD40.- Differentiation of Human Embryonic Stem Cells into Hematopoietic Cells In Vitro.- Gene Therapy to Improve Migration of T Cells to the Tumor Site.- Gene Therapy to Improve Function of T Cells for Adoptive Immunotherapy.- Cytokine-FC Fusion Genes as Molecular Adjuvants for DNA Vaccines.- Pharmacology of Anti-CD3 Diphtheria Immunotoxin in CD3 Positive T-Cell Lymphoma Trials.- Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display.- Identification of Immunogenic Peptides of the Self-Tumor Antigen: Our Experience with Telomerase Reverse Transcriptase.- Rescue, Amplification, Purification, and PEGylation of Replication Defective First-Generation Adenoviral Vectors.- Adenovirus-Mediated Interleukin (IL)-24 Immunotherapy for Cancer.- Liposomes for Gene Transfer in Cancer Therapy.- Oncolytic HSV as a Vector in Cancer Immunotherapy.- Generation of Chimeric T-Cell Receptor Transgenes and Their Efficient Transfer in Primary Mouse T Lymphocytes.- Multi-walled Carbon Nanotube (MWCNT) Synthesis, Preparation, Labeling, and Functionalization.- Cellular Immunotherapy of Cancer.